Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,883 | -20,894 | -14,239 | -13,427 | N/A |
| Depreciation Amortization | 520 | 965 | 674 | 695 | N/A |
| Other Working Capital | 17 | 307 | N/A | 343 | N/A |
| Other Operating Activity | 2,927 | 4,249 | 291 | 244 | 0 |
| Operating Cash Flow | $-22,419 | $-15,373 | $-13,274 | $-12,145 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -882 | -238 | -709 | 200 | N/A |
| Investing Cash Flow | $-882 | $-238 | $-709 | $200 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 23,736 | 0 | 1,000 | N/A |
| Debt Issued | 20,000 | 0 | 0 | 3,400 | N/A |
| Debt Repayment | -1,750 | -2,000 | -250 | -800 | N/A |
| Common Stock Issued | 142 | 40,503 | 207 | 14 | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -7 | N/A |
| Other Financing Activity | -26 | -1,679 | 16,726 | 3,500 | 0 |
| Financing Cash Flow | $18,366 | $60,560 | $16,683 | $7,107 | $N/A |
| Beginning Cash Position | 54,036 | 9,087 | 6,387 | 11,225 | N/A |
| End Cash Position | 49,101 | 54,036 | 9,087 | 6,387 | N/A |
| Net Cash Flow | $-4,935 | $44,949 | $2,700 | $-4,838 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,419 | -15,373 | -13,274 | -12,145 | N/A |
| Capital Expenditure | -882 | -244 | -709 | -2 | N/A |
| Free Cash Flow | -23,301 | -15,617 | -13,983 | -12,147 | 0 |